Breaking News, Financial News

Financial Report: Dr. Reddy’s 4Q10

North America revenue growth was 18% for the year, with 11 new product launches.

Dr. Reddy’s 4Q10

4Q Revenues: $453.0 million (+23%)

4Q Earnings: $75.0 million (+101%)

FY Revenues:
$1.7 billion (+6%)

FY Earnings: $248.0 million (earnings were $24.0 million FY10)

Comments: North America revenue growth was 18% for the year, with 11 new product launches. Russia had revenue growth of 29% with volume growth and OTC initiatives. India had revenue growth of 15%, with continued growth of key brands and new products. Germany revenue was down 17% in Euro terms, but had improved profitability. Global Generics revenue was $1.2 billion for the year (+10%), led by performance in North America and Emerging Markets.

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters